Kuichun Zhu

p53 induces TAP1 and enhances the transport of MHC class I peptides

Xinbin Chen, Jieyuan Jiang, J. Shou, 1999, Oncogene.

Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression

M. Kattan, T. Wheeler, S. Shariat, 2004, Clinical Cancer Research.

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Michael W Kattan, Kazumasa Matsumoto, M. Kattan, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutation spectrum of genes associated with steroid-resistant nephrotic syndrome in Chinese children.

Qingnan He, K. Zhu, X. Dang, 2017, Gene.

Farnesyltransferase inhibitors as anticancer agents: current status.

S. Sebti, A. Hamilton, K. Zhu, 2003, Current opinion in investigational drugs.

Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications.

Hong Yu, Jun Ye, K. Zhu, 2020, Biomedical reports.

High prevalence of DUOX2 gene mutations among children with congenital hypothyroidism in central China.

Yue Hu, K. Zhu, Hong Jiang, 2016, European journal of medical genetics.

Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing

Yue Hu, T. Xing, Hongtao Xu, 2015, Journal of Cancer.

Cytogenetic and genetic investigation of miscarriage cases in Eastern China

K. Zhu, Yu Zhang, Dong-lan Yuan, 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity

Jieyuan Jiang, K. Zhu, Wenjing Zhou, 1999, Oncogene.

Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells

F. Marincola, Helen Y Wang, Rong-Fu Wang, 2002, The Journal of experimental medicine.

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies

P. Hwu, G. Lizée, J. Abbruzzese, 2007, Cancer Immunology, Immunotherapy.

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.

P. Hwu, G. Lizée, J. Abbruzzese, 2007, Vaccine.

Downregulation of miRNA‐141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting

K. Zhu, Xin Zhou, Lu Han, 2017, Cancer medicine.